Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community

Tune in to our upcoming broadcast to learn about the latest advances in chronic lymphocytic leukmia and small lymphocytic lymphoma. Register today!

 

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
<< View More Conferences

2019 State of the Science Summit on Hematologic Malignancies in Chicago

Oncology Conference Multimedia
View more videos >>
Coming Soon
Oncology Conference Articles
Brentuximab Vedotin Solidified in Hodgkin Lymphoma, But Toxicity Concerns Remain
Brentuximab Vedotin Solidified in Hodgkin Lymphoma, But Toxicity Concerns Remain
Seo-Hyun Kim, MD, discusses frontline treatment considerations in stage III and IV classical Hodgkin lymphoma and exciting combinations on the horizon.
Ongoing Research Poised to Add Options for Myelofibrosis Treatment
Ongoing Research Poised to Add Options for Myelofibrosis Treatment
Jamile M. Shammo, MD, FASCP, FACP, discusses the current treatment paradigm of myelofibrosis, criteria for ruxolitinib resistance and intolerance, and promising agents on the horizon.
Novel Agents Strengthen Treatment Armamentarium in Non-Hodgkin Lymphoma
Novel Agents Strengthen Treatment Armamentarium in Non-Hodgkin Lymphoma
Parameswaran Venugopal, MD, discusses current and emerging treatment strategies in non-Hodgkin lymphoma.
AML Research Efforts in Full Swing After Decades of Stagnation
AML Research Efforts in Full Swing After Decades of Stagnation
Melissa L. Larson, MD, discusses available treatments for patients with acute myeloid leukemia, as well as others that are in the pipeline.
Exploration With Blinatumomab and CAR T-Cell Therapy Continues in ALL
Exploration With Blinatumomab and CAR T-Cell Therapy Continues in ALL
Joseph Wynne, MD, discusses ongoing studies with blinatumomab and CAR T-cell therapy in acute lymphoblastic leukemia, as well as the importance of assessing minimal residual disease in this space.
Novel Agents and Combos Continue to Transform Myeloma Paradigm
Novel Agents and Combos Continue to Transform Myeloma Paradigm
Agne Paner, MD, discusses the treatment paradigm in multiple myeloma and promising agents on the horizon.
Publication Bottom Border
Border Publication
 
x